Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients
Abstract Objectives The purpose of this study was to examine the treatment retention and efficacy of abatacept, the first member of a new class of biologic agents, in Japanese rheumatoid arthritis (RA) patients during clinical practice. Methods A retrospective multicenter study was conducted with pa...
Gespeichert in:
Veröffentlicht in: | Modern rheumatology 2013-09, Vol.23 (5), p.904-912 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Abstract
Objectives The purpose of this study was to examine the treatment retention and efficacy of abatacept, the first member of a new class of biologic agents, in Japanese rheumatoid arthritis (RA) patients during clinical practice.
Methods A retrospective multicenter study was conducted with patients who underwent abatacept therapy for 24 weeks (n = 143).
Results Patients at baseline had a mean age of 63.5 years, a mean disease duration of 11.3 years, and a mean disease activity score in 28 joints (DAS28) of 4.5. Overall retention of abatacept treatment was 83.2 % at 24 weeks, when 46.2 % of patients achieved DAS28-defined low disease activity (LDA; DAS28 |
---|---|
ISSN: | 1439-7595 1439-7609 |
DOI: | 10.3109/s10165-012-0760-4 |